Handelsbanken Fonder’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $297K | Sell |
24,202
-4,700
| -16% | -$57.7K | ﹤0.01% | 1429 |
|
2025
Q1 | $636K | Buy |
28,902
+5,300
| +22% | +$117K | ﹤0.01% | 1145 |
|
2024
Q4 | $535K | Hold |
23,602
| – | – | ﹤0.01% | 1257 |
|
2024
Q3 | $429K | Buy |
23,602
+4,400
| +23% | +$80K | ﹤0.01% | 1310 |
|
2024
Q2 | $560K | Buy |
19,202
+6,900
| +56% | +$201K | ﹤0.01% | 1109 |
|
2024
Q1 | $436K | Hold |
12,302
| – | – | ﹤0.01% | 1229 |
|
2023
Q4 | $536K | Buy |
12,302
+3,000
| +32% | +$131K | ﹤0.01% | 1112 |
|
2023
Q3 | $355K | Hold |
9,302
| – | – | ﹤0.01% | 1229 |
|
2023
Q2 | $383K | Hold |
9,302
| – | – | ﹤0.01% | 1215 |
|
2023
Q1 | $534K | Sell |
9,302
-2,400
| -21% | -$138K | ﹤0.01% | 981 |
|
2022
Q4 | $656K | Hold |
11,702
| – | – | ﹤0.01% | 817 |
|
2022
Q3 | $496K | Hold |
11,702
| – | – | ﹤0.01% | 968 |
|
2022
Q2 | $632K | Hold |
11,702
| – | – | ﹤0.01% | 889 |
|
2022
Q1 | $752K | Sell |
11,702
-2,300
| -16% | -$148K | ﹤0.01% | 930 |
|
2021
Q4 | $938K | Hold |
14,002
| – | – | ﹤0.01% | 933 |
|
2021
Q3 | $959K | Hold |
14,002
| – | – | 0.01% | 930 |
|
2021
Q2 | $955K | Buy |
14,002
+800
| +6% | +$54.6K | 0.01% | 949 |
|
2021
Q1 | $912K | Hold |
13,202
| – | – | 0.01% | 883 |
|
2020
Q4 | $857K | Hold |
13,202
| – | – | 0.01% | 893 |
|
2020
Q3 | $623K | Hold |
13,202
| – | – | ﹤0.01% | 897 |
|
2020
Q2 | $620K | Buy |
+13,202
| New | +$620K | 0.01% | 862 |
|